The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer
Abstract RNA-based therapeutics are emerging as innovative options for cancer treatment, with microRNAs being attractive targets for therapy development. We previously implicated microRNA-642a-5p (miR-642a-5p) as a tumor suppressor in prostate cancer (PCa), and here we characterize its mode of actio...
Guardado en:
Autores principales: | Dianne J. Beveridge, Kirsty L. Richardson, Michael R. Epis, Rikki A. M. Brown, Lisa M. Stuart, Andrew J. Woo, Peter J. Leedman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb9118786c3647f78f95a546270cae69 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tratamiento del Tumor de Wilms
por: Zolezzi R,Paola, et al.
Publicado: (1987) -
Tumor de Wilms: Hallazgo coincidente
por: Jaime Galindo López, et al.
Publicado: (2006) -
Neuroblastoma intrarenal mimetizando tumor de Wilms
por: Maria T. Cartaxo Muniz, et al.
Publicado: (2005) -
Wilm’s tumor 1 promotes memory flexibility
por: Chiara Mariottini, et al.
Publicado: (2019) -
Tumor de Wilms: Histologic Forms and Prognosis
por: Las Heras B,Jorge, et al.
Publicado: (1986)